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Abstract
Background: Epistasis is one of the central themes in viral evolution due to its importance in drug resistance,
immune escape, and interspecies transmission. However, there is a lack of experimental approach to systematically
probe for epistatic residues.
Results: By utilizing the information from natural occurring sequences and high-throughput genetics, this study
established a novel strategy to identify epistatic residues. The rationale is that a substitution that is deleterious in one
strain may be prevalent in nature due to the presence of a naturally occurring compensatory substitution. Here,
high-throughput genetics was applied to influenza A virus M segment to systematically identify deleterious
substitutions. Comparison with natural sequence variation showed that a deleterious substitution M1 Q214H was
prevalent in circulating strains. A coevolution analysis was then performed and indicated that M1 residues 121, 207,
209, and 214 naturally coevolved as a group. Subsequently, we experimentally validated that M1 A209T was a
compensatory substitution for M1 Q214H.
Conclusions: This work provided a proof-of-concept to identify epistatic residues by coupling high-throughput
genetics with phylogenetic information. In particular, we were able to identify an epistatic interaction between M1
substitutions A209T and Q214H. This analytic strategy can potentially be adapted to study any protein of interest,
provided that the information on natural sequence variants is available.
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Background
Epistasis is a critical factor in viral evolution [1, 2], in
which the phenotypic effect of a given mutation varies
under different genetic backgrounds. The importance of
epistasis has been demonstrated in drug resistance [3–5],
immune escape [6, 7], and cross-species adaptation [8].
Therefore, identification of pairwise epistatic interaction
offers valuable information to understand the functional
basis of viral evolution in nature.
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Several virus sequence databases are publicly available
[9–11], which permit interrogation of evolutionary path-
ways in nature and allow approximation of the chrono-
logical order of mutation accumulation [6, 12]. Numerous
computational algorithms and analytical tools have been
developed to identify molecular interactions based on
coevolving residues (reviewed in [13]). Such phylogenetic
information may lead to the identification of epistatic
interactions [5, 12]. However, coevolving mutations may
be attributed to genetic drift and hitchhiking, which can
be pervasive in evolution [14–16], rather than epistatic
interactions. Subsequently, many different combinations
of mutations have to be individually constructed and ana-
lyzed to discern epistatic residues. It becomes inefficient
to probe for epistatic interaction based on coevolutionary
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analysis without any prior knowledge of the mutational
fitness effect.
Recently, high-throughput genetics becomes a popular
strategy to profile the fitness effects of a large number of
mutations in parallel [17]. The basis of high-throughput
genetics is to generate a panel of mutations using high-
throughput mutagenesis, and to use deep sequencing to
monitor the occurrence frequency of individual muta-
tions when selection is imposed. The change of frequency
of each mutation can then be translated into a fitness
effect. High-throughput genetics opens up the opportuni-
ties to identify critical residues in the protein of interest
under any given selection condition. A medically impor-
tant application is to systematically investigate the effects
of mutations in a virus gene or genome [18–23]. It has
been shown that high-throughput genetics facilitates the
identification of drug resistance substitutions [18], anti-
interferon residues [24], and understanding of the evolu-
tion of circulating viral strains [20].
High-throughput genetics is often applied to examine
mutational fitness effect under only one genetic back-
ground of a virus species in one study. However, due to
epistasis, a given mutation may have a very different fit-
ness effect among different genetic backgrounds in nature
[12, 25]. Therefore, it is not surprising that some muta-
tions with a low replication fitness in a laboratory strain
can be prevalent in nature. Indeed, such observation has
been made in a high-throughput genetics study of the
influenza A virus hemagglutinin protein [21]. However,
it is not always straightforward to identify the genetic
determinant underlying the epistatic effect.
Matrix (M) segment is of the influenza A virus encodes
two proteins, namely M1 and M2. M1 is the matrix pro-
tein that forms a protein coat inside the viral envelop. It
plays an important role in virus assembly and budding
[26, 27]. M2 is a proton-selective ion channel that facil-
itates the uncoating of virions in the infected cells [28].
In addition, both M1 and M2 are critical determinants in
the morphology of the viral particles [29]. While M2 is a
major target for the development of anti-influenza drug
[30], resistance mutations can rapidly emerge without any
cost on viral replication fitness [31, 32]. On the other
hand, being a highly conserved protein, M1 is an effective
antigen to drive heterosubtypic protection through T-cell
immunity [33, 34]. In fact, M1 has been used as a target for
the development of T-cell-based vaccine against influenza
virus [35]. Due to the biomedical significance of the M
segment of influenza A virus, it is important to compre-
hend the fitness consequences of individualmutations and
epistatic interactions among mutations in M1 and M2.
In this study, we described an approach to iden-
tify pairwise epistatic interaction by coupling high-
throughput genetics with phylogenetic information. Using
high-throughput genetics, we were able to systematically
identify deleterious substitutions in the M segment of
influenza virus A/WSN/33. Three substitutions that were
classified as deleterious were prevalence in the circulating
strains. A phylogenetic analysis on the circulating strains
was then performed to examine whether those substi-
tutions of interest were coevolving with other residues.
These analyses led us to identify and experimentally vali-
date the epistatic interaction between A209T and Q214H,
in which A209T was able to compensate the delete-
rious effect of Q214H. Interestingly, both substitutions
were prevalent in the 2009 pandemic swine influenza
virus strains, but not in the seasonal influenza virus
strains. This study demonstrates the power of combining
high-throughput genetics and phylogenetic information
to identify epistatic residues.
Results
Methodology overview and experimental design
The goal of this study was to develop a methodol-
ogy to systematically identify pairwise epistatic inter-
action, more specifically between deleterious mutations
and compensatory mutations. We proposed to couple
high-throughput genetics with phylogenetic information
to achieve such purpose (Fig. 1a). First, high-throughput
genetics could be utilized to identify deleterious muta-
tions. Second, sequence database was explored to deter-
mine whether any of those deleterious mutations could
be observed in naturally occurring sequences. Third, if
a deleterious mutation could be observed in naturally
occurring sequences, a coevolution analysis would be
performed to identify potential compensatory mutations.
Such putative epistatic interaction would then need to be
confirmed experimentally. In this study, we provided a
proof-of-concept using the M segment of influenza virus.
High-throughput genetics has been applied to study 7
out of 8 segments of influenza A virus genome, which
include PB2 segment [36], PB1 segment [36], PA segment
[23, 36], HA segment [19, 21], NP segment [20], NA seg-
ment [37], and NS segment [24]. In this study, the M
segment was analyzed by high-throughput genetics. Two
different mutant libraries were built, namely the whole
segmentmutant library and “small libraries”. For the whole
segment mutant library, the entire M segment was sub-
jected to mutagenesis. In contrast, for each “small library”,
only a 240-bp region was mutagenized. ∼94 % of the
nucleotide position of the M segment was covered by the
whole segment mutant library, or by four different “small
libraries”.
Each mutant library was transfected in 293T cells and
the resultant viral mutant library was used to infect A549
cells for 24 hours (Fig. 1b). Both the plasmid mutant
library and the post-infection mutant library were sub-
jected to deep sequencing. Biological replicates were
obtained by independent transfection and infection. We
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Fig. 1Methodology overview and experimental design. a The proposed workflow for identifying pairwise epistatic interaction is shown. Key
methodologies are boxed. b The experimental scheme is shown. Briefly, 293T cells (represented by the red flask) were transfected with the
randomly mutagenized M segment (DNA library) and the other seven WT segments to generate the viral mutant library. This viral mutant library was
used to infect A549 cells (represented by the orange flask) for 24-hour to generate the post-infection library. The DNA library and the post-infection
library were subjected to deep sequencing
have included two biological replicates for the whole seg-
ment mutant library (replicate 1 and 2) and three biolog-
ical replicates for each of the “small libraries” (replicate 3
to 5). The sequencing coverage for each sample is shown
in Table 1.
Estimation of fitness effect for individual point mutations
Relative fitness index (RF index), which was com-
puted as the enrichment ratio of the relative occur-
rence frequencypost−infection to the relative occurrence
frequencyplasmid mutant library [19, 23], was used as a proxy
for the fitness effect of individual point mutations. For
Table 1 Sequencing coverage
Replicate Library type Average Minimum Maximum
coverage coverage coverage
DNA input Whole segment 157,846 82,998 189,371
DNA input Small libraries 54,850 44,297 105,183
1 Whole segment 242,390 158,210 276,850
2 Whole segment 43,286 11,451 131,578
3 Small libraries 59,694 30,003 113,619
4 Small libraries 50,758 29,606 91,134
5 Small libraries 63,659 18,201 104,731
For those replicates with the library type indicated as “Whole Segment”, the
coverage represents the number of error-corrected reads [19]. For those replicates
with the library type indicated as “Small Libraries”, the coverage represents the
number of sequencing reads
each point mutation, five independent RF indices were
obtained from five replicates. Although the distribution
of RF index in different replicates are similar (Fig. 2a),
the Spearman’s rank correlation coefficient between RF
indices for individual mutations across different replicates
is only moderate, ranging from 0.53 to 0.67 (Table 2).
The lack of a strong correlation can be attributed to the
bottleneck of genetic diversity in the transfection step as
described in other high-throughput genetic studies using
the influenza reverse genetic system [20, 21]. This bottle-
neck would result in a limited number of virus mutations
being reconstituted from the plasmid mutant library. In
other words, even though somemutations were present in
the plasmid mutant library, they may not be reconstituted
into the viral mutant library due to the bottleneck in the
transfection step. Those mutations that were not reconsti-
tuted into the viral mutant library may not be deleterious,
but would be identified as deleterious due to their absence
in the post-infection pool. This bottleneck can be viewed
as an incomplete sampling process of the plasmid mutant
library. Our recent study suggested that the bottleneck
effect could be relieved by scaling up the transfection by
using more DNA plasmid and more 293T cells [23].
Systematic identification of deleterious mutations
The ratio of true positive rate (TPR) to false positive rate
(FPR) was used to evaluate the statistical confidence in the
identification of deleterious mutations. In the following,





Fig. 2 Systematic identification of deleterious mutations. a The distributions of RF index in different replicates are shown as violin plots. The white
circle at the center represents the median and the black box represents the interquartile range. RF index of < 0.001 was set to 0.001 here for
visualization purpose. b The ratio of true positive rate (TPR) to false positive rate (FPR) for classifying deleterious mutations was evaluated across
different cutoffs. All five replicates were used in this analysis. c The ratio of TPR to FPR for classifying deleterious mutations was computed as the
number of replicate being used to generate RF index increases. b and c RF indexmax , RF indexmean , and RF indexmedian were analyzed. The red line
represents RF indexmax . The grey line represents RF indexmean . The black line represents RF indexmedian . d The distributions of RF indexmax for silent
mutations, nonsense mutations, and missense mutations are shown as histograms. The shaded area represents the range of RF indexmax where
mutations were identified as deleterious. The percentage of mutations being identified as deleterious is indicated. e The composition of RF
indexmax is shown as a pie chart
this ratio would be abbreviated as TPR/FPR. TPR was
computed as the fraction of nonsense mutations, which
were expected to be phenotypically lethal, being identi-
fied as deleterious. FPR was computed as the fraction of
silent mutations, which were expected to be phenotyp-
ically neutral, being identified as deleterious. TPR/FPR
could be regarded as a measure of signal-to-noise ratio for
Table 2 Correlations of fitness profile across replicates
Correlation Replicate 1 Replicate 2 Replicate 3 Replicate 4 Replicate 5
Replicate 1 1.00 0.67 0.61 0.56 0.53
Replicate 2 0.67 1.00 0.59 0.57 0.54
Replicate 3 0.61 0.59 1.00 0.56 0.58
Replicate 4 0.56 0.57 0.56 1.00 0.55
Replicate 5 0.53 0.54 0.58 0.55 1.00
The Spearman’s rank correlation coefficient between RF indices for individual
mutations across different replicates are shown
the identification of deleterious mutations. A larger value
of TPR/FPR represented a higher confidence in the iden-
tification of deleterious mutations. We acknowledged that
FPR may be slightly overestimated because it is known
that some silent mutations may impose a fitness cost.
We tested different cutoffs for RF index for the iden-
tification of deleterious mutations (Fig. 2b). To compile
the five RF indices from five replicates (two whole seg-
ment mutant library replicates and three “small libraries”
replicates) into one single RF index for a given muta-
tion, we proposed three different measures: 1) the highest
value among the five RF indices from those five replicates
(RF indexmax) was used, 2) the average value of the five
RF indices from those five replicates (RF indexmean) was
used, and 3) the median value of the five RF indices from
those five replicates (RF indexmedian). A mutation would
be identified as deleterious when its RF index was less than
the indicated cutoff. Here, all three measures of RF index
(RF indexmax, RF indexmean, and RF indexmedian) were
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tested against seven different cutoffs, ranging from 2-fold
to 8-fold decreased in relative occurrence frequency from
plasmid mutant library to post-infection library (equiva-
lent to an RF index of 1/2 = 0.5 to 1/8 = 0.125). The
TPR/FPR of both RF indexmean and RF indexmedian were
lowered than that of RF indexmax across all tested cutoff.
This indicates that RF indexmax would give the highest
confidence among all three measures of RF index in iden-
tifying deleterious mutations. For RF indexmax, TPR/FPR
was peaked at 36.8 with a cutoff of 6-fold decreased in rel-
ative occurrence frequency (RF indexmax = 1/6 ≈ 0.167).
In other words, there would be a 36.8-fold enrichment
of deleterious mutations over non-deleterious mutations
using a 6-fold cutoff for RF indexmax.
We further tested the impact of including different
number of replicates on the confidence in the identifica-
tion of deleterious mutations. A monotonic increase in
TPR/FPR was observed as more replicates were included
in the calculation of RF indexmax, indicating the benefit
of having more replicates in the identification of delete-
rious mutations (Fig. 2c). In contrast, an increase in the
number of replicate did not increase TPR/FPR for both RF
indexmean and RF indexmedian. Again, this result shows the
advantage of using RF indexmax instead of RF indexmean or
RF indexmedian in the identification of deleterious muta-
tions. Subsequently, a 6-fold cutoff for RF indexmax was
employed for the rest of this study, in which 1.8 % of silent
mutations, 67 % of nonsense mutations, and 51 % of mis-
sense mutations were identified as deleterious (Fig. 2d).
We postulated that due to the presence of the bottleneck
effect in the transfection step, the usage of RF indexmax
was more efficient than RF indexmean and RF indexmedian
in the identification of deleterious mutations. As men-
tioned above, bottleneck effect in the transfection step
would lead to a neutral mutation being identified as a
deleterious mutation. However, since the bottleneck was
independent in each replicate, the probability for a neu-
tral mutation being identified as neutral in at least one
replicate increased as the number of replicates increased.
Whereas a deleterious mutation should be identified as
deleterious regardless of the number of replicates. There-
fore, the power of using RF indexmax to distinguish
deleterious mutations versus non-deleterious mutations
would increase as the number of replicates increased.
In contrast, as our results suggest, the power of using
RF indexmean or RF indexmedian to distinguish deleteri-
ous mutations versus non-deleterious mutations would
not benefit from an increasing number of replicates. Since
the goal here was to confidently identify deleterious muta-
tions using the data from five replicates, the usage RF
indexmax, was more suitable than RF indexmean or RF
indexmedian.
The composition of the RF indexmax was examined
(Fig. 2e). Replicate 2 contributed the most to the RF
indexmax, in which 30 % of the RF indexmax came from
replicate 2. Replicate 5 contributed the least to the RF
indexmax, in which 15 % of the RF indexmax came from
replicate 5. This variation in contribution to RF indexmax
was likely due to different degrees of bottleneck effect in
each replicate.
Validation and functional relevance of the high-throughput
genetics result
To experimentally confirmed the reliability of our dataset,
we randomly selected and individually reconstructed 13
substitutions onM1 that were identified as deleterious (RF
indexmax < 0.167). A virus rescue experiment was per-
formed to assess the fitness effect of these substitutions.
Seven substitutions (K21Q, R78P, A186P, G136R, K47T,
I107M, and D30G) had undetectable viral titer, three sub-
stitutions (V219L, R49K, and P50S) had two-log drop in
viral titer as compared to wild-type (WT), two substitu-
tions (T169P and T139S) had one-log drop in viral titer as
compared to WT, and only one substitution (S70T) had
WT-like viral titer (Fig. 3). Overall, 12 out of 13 substitu-
tions displayed a deficiency in viral replication. Note that,
deficiency in viral replication was defined by at least 10-
fold decrease in viral titer in the rescue experiment, which
was a reasonable cutoff as indicated by a large-scale muta-
tional analysis of influenza A virus nucleoprotein [38].
This experiment validated our approach in identifying
deleterious substitutions.
We aimed to further confirm the functional relevance
of our the high-throughput genetics data by analyzing
the essentialness of individual residues. For each amino
acid residue, essentialness was computed as the frac-
tion of profiled substitutions being deleterious (Fig. 4a-
b). In general, residues on M1 protein (mean essen-
tialness = 0.55, median essentialness = 0.5) were
more essential, hence less mutable, than residues on
M2 protein (mean essentialness = 0.19, median essen-
tialness = 0) (P = 1.7 × 10−15, Wilcoxon rank-sum
test). Projecting the essentialness on the structure of
Fig. 3 Validation of the profiling result by virus rescue experiment.
Based on the profiling result, 13 randomly selected deleterious
substitutions (RF indexmax < 0.167) were reconstructed and analyzed
by virus rescue experiment. The TCID50 measured from the virus
rescue experiment is shown. The grey dashed line represents the
lower detection limit
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M1 revealed the non-mutability of the M1-M1 inter-
face (Fig. 4c), which was important for the oligomer-
ization of M1 [39] and was required for matrix layer
formation during assembly and budding [40]. A quan-
titative analysis was performed to compare the essen-
tialness of buried residues, residues at the dimeric
interface, and other surfaced-exposed residues (see
“Methods” section for the classification scheme). The
essentialness for residues at the dimeric interface is signif-
icantly higher than that of other surface-exposed residues
(P = 0.04, Wilcoxon rank-sum test) (Fig. 4d). In fact,
the essentialness of buried residues is also signifi-
cantly higher than that of other surface-exposed residues
(P = 0.04, Wilcoxon rank-sum test) but has no significant
difference with that of residues at the dimeric interface
(P = 0.33, Wilcoxon rank-sum test). This analysis con-
firmed the essentialness of the M1-M1 interface.
For M2, only two highly essential residues, H37 and
W41, were observed on the structure (Fig. 4e). These
two residues are absolutely required for the ion channel
function [41, 42], in which H37 acts as a selectivity filter




Fig. 4 Functional relevance of the profiling result. a At each amino acid residue, essentialness represents the fraction of profiled substitutions being
deleterious. The essentialness for those residue with ≥ 2 substitutions being profiled is shown. Each data point is colored according to the value of
essentialness: essentialness = 0 (blue), 0 < essentialness ≤ 0.25 (marine), 0.25 < essentialness ≤ 0.5 (white), 0.5 < essentialness ≤ 0.75 (orange), 0.75
< essentialness ≤ 1 (red). b The distributions of essentialness for individual residues on M1 and M2 are shown as boxplots. c The essentialness is
projected on the structure of homodimer of M1 N-terminal domain (PDB: 1EA3) [39]. Residues are color-coded as that of panel a. Those residues
with < 2 substitutions being profiled is colored in grey. d Individual residues on M1 N-terminal domain were categorized into buried residues,
surface-exposed residues at the homodimer interface, and other surface-exposed residues. The distributions of essentialness for these three
categories are shown as boxplots. e The essentialness is projected on the structure of homotetramer of M2 ion channel (PDB: 2RLF) [72]. Residues
are color coded according to that of panel a. Those residues with < 2 substitutions being profiled is colored in grey
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these analyses demonstrate the functional relevance of our
high-throughput genetics result.
Discrepancy between natural sequence variation and
fitness profiling data
We were mostly interested in identifying and studying
those deleterious substitutions that were prevalent in
nature, if any. We then compared the RF indexmax and
the natural occurrence frequency for individual substi-
tutions. This comparison was done separately for H1N1
seasonal influenza viruses (seasonal flu) and 2009 H1N1
pandemic swine influenza viruses (swine flu) using the
sequence information retrieved from Influenza Research
Database [47]. Interestingly, we identified three substitu-
tions that appeared as deleterious in our high-throughput
genetics data (RF indexmax < 0.167), yet were preva-
lence in naturally occurring influenza sequences (natural
occurrence frequency> 50 %) (Fig. 5). These three substi-
tutions were C50S on M2 (RF indexmax = 0.05), D231N
on M1 (RF indexmax = 0.15), and Q214H on M1 (RF
indexmax = 0.16). These three substitutions were individ-
ually reconstructed. The deleterious effects of M1 Q214H
andM1 D231N were validated by virus rescue experiment
(Fig. 6b). In fact, the deleterious effect of M1 D231N was
also previously demonstrated in another genetic back-
ground [48]. However, M2 C50S, which was shown to be a
non-essential palmitoylation site [49], had no fitness cost
in the virus rescue experiment (Fig. 6b). We postulated
that either C50S was a false positive from the identifica-
tion of deleterious mutations or with a fitness cost that
could only be detectable under a competitive growth envi-
ronment which resembled that of the high-throughput
genetics experiment. Consequently, M2 C50S was ignored
in the downstream analysis.
Identification of potential compensatory substitutions by
coevolution analysis
Next, we aimed to investigate the genetic mechanism
of the prevalence of those deleterious substitutions in
nature. One possibility was that the fitness effects of
those substitutions were genetic background-dependent.
In other words, substitutions which appeared as delete-
rious in strain A/WSN/33, the strain employed in this
study, may have no fitness cost in other virus strains. We
hypothesized that compensatory substitutions for those
deleterious substitutions may exist in certain naturally
Fig. 5 Comparison between natural variation and profiling result. The relationship between RF indexmax for individual amino acid substitutions and
the occurrence frequency in natural circulating strains is shown. This comparison was performed on both M1 and M2 proteins with seasonal
influenza virus strains (Seasonal flu) and 2009 pandemic swine influenza virus strains (Pandemic flu) being analyzed independently. The grey dashed
line represents the cutoff for classifying mutations as deleterious
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Fig. 6 A209T as a compensatory substitution for Q214H. a The result from coevolution analysis on M1 protein using CAPS [50] is shown as a
network. Each node represents a residue and is labeled with the amino acid position. Nodes representing residue on N-terminal domain (residues
1–164) are in rectangular shape. Nodes representing residue on C-terminal domain (residues 165–252) are in eclipse shape. An edge is drawn
between coevolving residues. Residues 121, 207, 209, and 214 were identified as a coevolving group by CAPS [50] and are highlighted in cyan. b The
TCID50 measured from the virus rescue experiment for the wild-type (WT) or the indicated mutant is shown. This data represent the mean value
from three independent replicates. The grey dashed line represents the lower detection limit. c A multicycle replication assay was performed. A549
cells were infected with wild-type (WT) or the indicated mutant at an MOI of 0.005. Virus was harvested at the indicated timepoints and the TCID50
was measured
occurring strains. Those compensatory substitutions, if
they exist, could potentially be identified using phyloge-
netic information.
Subsequently, a coevolution analysis using CAPS [50]
was performed to search for intra-protein coevolving
residues (Fig. 6a). CAPS was featured by its ability to elim-
inate background correlations and minimize stochastic
dependencies between sites using phylogenetic informa-
tion. Thus, it possessed a lower false positive rate and
a higher sensitivity as compared to other algorithms for
detecting coevolving residues [51]. Here, CAPS was able
to identified four residues (residues 121, 198, 207 and 209)
on M1 that were coevolving with residue 214. In addition,
CAPS detected that residues 121, 207, 209, and 214 were
coevolved as a group. Residues 207 and 209 were located
on the structurally unresolved M1 C-terminal domain
(amino acid residues 165–252) along with residue 214,
while residue 121 was located on M1 N-terminal domain
(amino acid residues 1–164). Nonetheless, no residue was
found to coevolve with residue 231 on M1. As a result,
our analysis below focused on residue 214 and the two
coevolving residues 207 and 209 that were located in the
same protein domain. A significant difference in amino
acid usage at these sites was detected between seasonal flu
and swine flu. For seasonal flu, glutamine [Q] dominated
at residue 214 (99 %), serine [S] dominated at residue 207
(93 %), and alanine [A] dominated at residue 209 (98 %).
For swine flu, histidine [H] dominated at residue 214
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(98 %), threonine [T] dominated at residue 209 (99 %), and
asparagine [N] dominated at residue 207 (99 %). There-
fore, we hypothesized that the replication defect of Q214H
could be compensated by either S207N or A209T, or both
of them.
We also examined the natural variant at residue 198,
which was also located in the C-terminal domain and
shown to be coevolving with residue 214 (Fig. 6a).
Nonetheless, glutamine [Q] was dominated at residue 198
(99 %) regardless of whether the amino acid at residue 214
was glutamine [Q] or histidine [H]. It suggests that, at least
in natural evolution, mutation at residue 198 was unlikely
to impose a significant compensatory effect on the fitness
cost Q214H.
A209T is a compensatory substitution for Q214H
To test our hypothesis, the fitness effects of S207N and
A209T on Q214H were tested by virus rescue experi-
ment. While the addition of S207N further decreased the
viral titer, addition of A209T fully restored the viral titer
to WT level (Fig. 6b). A multicycle replication assay was
also performed. The viral titer of Q214H was ∼100-fold
lower than WT across different time points (Fig. 6c). This
defect was rescued with the addition of A209T. How-
ever, A209T alone did not improve the replication kinet-
ics above the wild type. Together, these results showed
that A209T could act as a compensatory substitution for
Q214H. In fact, A209T and Q214H were both located
at a putative α-helix, helix 12 (amino acid residues 197–
218), of the M1 C-terminal domain [52, 53]. It has been
shown that residue 209 was one of the determinants of
influenza virion morphology and spreading kinetics [54],
whereas residue 214 was involved in adaptation to mice
[55]. In addition, most single-amino acid substitutions at
their neighboring residues, namely 210, 211, 212 and 213,
were shown to attenuate the viral growth [56]. Together
with our results, these evidences support the functional
importance of residues 209 to 214 in viral replication.
We further speculate that additional epistatic interactions
may be present in this region.
The interaction between A209T and Q214H in M1
demonstrates the feasibility of identifying epistatic
residues through an integration of high-throughput genet-
ics and phylogenetic information. This analytic strategy
is generally applicable to any viral gene of interest, pro-
vided that the information on natural sequence variants is
available.
Discussion
High-throughput genetics has been applied to many dif-
ferent genes to quantify the fitness effects of a large
number of single-mutations in parallel [17]. However,
high-throughput genetics alone is not sufficient to identify
epistatic interactions between sites. Although our recent
study has successfully profile all pairwise epistatic inter-
actions in a 56-residue protein domain [57], the mutant
library complexity, hence the cost, of such approach
increases polynomially with the length of the protein.
Consequently, the feasibility of profiling epistasis using
high-throughput genetics alone is limited to small protein
domains. By combining high throughput genetics with
a phylogenetically-corrected analysis of co-evolving sites
in naturally occurring sequence datasets, our approach
permits the identification of epistatic residues.
Here, high-throughput genetics is performed on
influenza virus A/WSN/33, which is a relatively old strain.
However, most part of the high-throughput genetics data
obtained in this study should be applicable to more recent
strains. Previous studies have shown that high-throughput
genetics data obtained from strain A/WSN/33 allowed
an accurate modeling of natural evolution of influenza
A virus across several decades [20, 21]. Furthermore, a
recent study showed that two sets of high-throughput
genetics data obtained from two strains separated by
more than three decades were highly correlated [58].
Therefore, we postulate that most deleterious mutations
identified in this study should carry a fitness cost when
they are introduced to more recent strains. Nonetheless,
we also acknowledge that additional epistatic interactions
may be identified if our high-throughput genetics analysis
is performed on more than one strain.
While this study focuses on a single gene, our approach
can potentially be applied to study intergenic epistatic
interaction. The biomedical relevance of intergenic epista-
sis can be highlighted by human immunodeficiency virus
(HIV) resistance to protease inhibitor, in which substitu-
tions on gag can compensate the deleterious effect asso-
ciated with the drug resistance substitutions on protease
[59, 60]. In fact, coevolution analysis is a major bioin-
formatics approach to predict protein-protein interaction
[13]. We propose that by coupling with coevolution anal-
ysis of an appropriate sequence dataset, high-throughput
genetics can be applied to any given interacting protein
pair to search for interacting residues. Nevertheless, we do
acknowledged that correlated evolution between proteins
can be dominated by similar constraints on evolutionary
rate but not coevolution per se [61]. Therefore, adapt-
ing our method to search for intergenic epistasis may be
more challenging than to identify intragenic epistasis as
described in this study.
Compensatory mutation is a type of sign epistasis [62].
In the presence of sign epistasis, the fitness effect of
a given mutation could exhibit different sign (benefi-
cial, deleterious, or neutral) depending on the genetic
background. On the other hand, for magnitude epis-
tasis, the fitness effect of a given mutation would
not change sign, but would display a different magni-
tude depending on genetic background. Although our
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approach is able to identify sign epistasis, it may be
difficult to adapt our approach to search for magni-
tude epistasis, which has a more subtle impact in fitness
effect. Consequently, identification of magnitude epis-
tasis would require a more accurate quantification of
mutational fitness effects and a more sophisticated anal-
ysis to infer mutational fitness effect using phylogenetic
information.
Recently, there is an increasing interest in higher-
order epistasis, which describes the epistatic interac-
tion between more than two mutations [63]. While this
study focuses on pairwise epistasis, we propose that our
approach can be adapted to search for higher-order epis-
tasis. For example, higher-order epistasis can potentially
be identified by deleterious mutations that emerged as a
group in natural evolution, where each mutation within
the group alone is deleterious but the entire group of
mutations together has a neutral or beneficial fitness
effect. Therefore, combining phylogenetic information
and high-throughput genetics can potentially facilitate the
understanding of higher-order epistasis in natural evolu-
tion.
During the course of our work, Melamed et al. pub-
lished a study that integrated high-throughput genet-
ics with multiple sequence alignment of evolutionarily
divergent variants to identify protein-binding sites on
Saccharomyces cerevisiae poly(A)-binding protein, Pab1
[64]. More specifically, they have demonstrated that dele-
terious substitutions that naturally existed could be due
to the evolutionary divergence of functional interface.
While their aim and approach are different from our work
here, both Melamed et al. and this study suggest that
high-throughput genetics and natural sequence variation
can be synergistic for mapping protein sequence-function
relationship.
Our recent study has indicated that functional residues
can be efficiently identified by combining protein struc-
ture information and high-throughput genetics [23]. In
this study, protein structure information was not exten-
sively utilized due to the absence of structural information
in the region of interest (M1 C-terminal domain). Nev-
ertheless, it is shown that combining coevolution analysis
with structural information improves the identification
of residue interactions [65], and helps classify the type
of coevolution (functional versus structural coevolution)
[50, 66]. Therefore, protein structure information can be
highly valuable for mapping epistatic interaction. Future
approach for studying second or higher-order interactions
may integrate phylogenetic information, protein structure
information and high-throughput genetics.
Conclusions
This work demonstrates a hybrid strategy to identify
epistatic residues by combining phylogenetic information
and high-throughput genetics. We successfully identified
the epistatic interaction between influenza A virus M1
substitutions A209T and Q214H. While our proof-of-
concept is based on a viral protein, our approach can
potentially be applied to probe for epistatic residues in
any protein of interest, provided that the phylogenetic
information is available.
Methods
Viral mutant library and point mutations
In this study, M segment of influenza virus was ana-
lyzed by high-throughput genetics. To increase the
statistical confidence in the fitness profiling result,
two different mutant library building strategies were
employed in this study, namely the whole segment
mutant library and the “small libraries”. The method-
ologies for construction of these two libraries using
error-prone PCR were described in our previously stud-
ies [19, 23]. For the whole segment mutant library,
the entire M segment was subjected to mutagenesis.
The M segment mutant library plasmids for both the
whole segment mutant library or the “small libraries”
were created by performing error-prone PCR on the M
segment of the eight-plasmid reverse genetics system
of influenza A/WSN/1933 (H1N1) [67]. Mutated insert
was generated by PCR using error-prone polymerase
Mutazyme II (Stratagene, La Jolla, CA) with the following
primers:
Whole segment library insert: 5’-GTG TGT CGT
CTC GGG AGC AAA AGC AGG TAG ATA TTG
AAA GAT G-3’ and 5’-GTG TGT CGT CTC GTA
TTA GTA GAA ACA AGG TAG TTT TTT ACT
CC-3’
Small library 1 insert: 5’-AAG CAG CGT CTC ATT
GAA AGA TGA GTC TTC TAA CC-3’ and 5’-AAC
TGC CGT CTC AAT GTT ATT TGG ATC TCC
GTT CCC-3’
Small library 2 insert: 5’-CAC GTC TCA GCT TTG
TCC AAA ATG CTC TTA AT-3’ and 5’-CAC GTC
TCA TTA GTG GAT TGG TTG TTG TCA C-3’
Small library 3 insert: 5’-CAC GTC TCA GCA TCG
GTC TCA TAG GCA AAT G-3’ and 5’-CAC GTC
TCA ACT TGA ATC GTT GCA TCT GCA C-3’
Small library 4 insert: 5’-CAC GTC TCA GAT GAT
CTTCTTGAAAATTTACAG-3’ and 5’-CACGTC
TCA CAG CTC TAT GTT GAC AAA ATG A-3’
The BsmBI-digested pHW2000 plasmid [67] was used
as the vector for the whole segment mutant library,
whereas the corresponding vector for each of the three
“small libraries” was generated by PCR with KOD DNA
polymerase (EMD Millipore, Billerica, MA) using the fol-
lowing primers:
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Small library 1 vector: 5’-CAC GTC TCA TCA ATA
TCT ACC TGC TTT TGC TC-3’ and 5’-CAC GTC
TCA ACA TGG ACA AAG CAG TTA AAC TG-3’
Small library 2 vector: 5’-CAC GTC TCA AAG CGT
CTA CGC TGC AGT CCC-3’ and 5’-CAC GTC
TCA CTA ATC AGA CAT GAG AAC AGA AT-3’
Small library 3 vector: 5’-CAC GTC TCA ATG CTG
GGA GTC AGC AAT CTG TT-3’ and 5’-CAC GTC
TCA AAG TGA TCC TCT CGT CAT TGC AG-3’
Small library 4 vector: 5’-CAA CGT CTC ACA TCT
TTT AGA CCA GCA CTG GAG CTA G-3’ and
5’-TTG TCA CGT CTC AGC TGG AGT AAA AAA
CTA CCT TG-3’
Both the insert and the vector were then digested
by BsmBI (New England Biolabs, Ipswich, MA). For
each mutant library, The corresponding insert and vec-
tor were ligated using T4 DNA ligase (Life Technologies,
Carlsbad, CA), and transformed into electrocompetent
MegaX DH10B T1R cells (Life Technologies). Subse-
quently,∼200,000 colonies were scraped and directly pro-
cessed for plasmid DNA purification (Qiagen Sciences,
Germantown, MD). Point mutations for the validation
experiment were constructed using the QuikChange XL
Mutagenesis kit (Stratagene) according to the manufac-
turer’s instructions.
The whole segment mutant library and the “small
libraries” had their own pros and cons associated with
the deep sequencing strategy. Illumina MiSeq 2 × 250
bp sequencing was employed in the “small libraries”
approach. Since each sequencing read covered the entire
mutagenized region, the haplotype for a given clone could
be examined. Therefore, fitness effects arouse frommuta-
tion interactions could be filtered in the “small libraries”
approach. In contrast, genetic linkage between mutations
could not be addressed in the whole segment library due
to the long span of the mutagenized region. Thus, fitness
effects arouse from mutation interactions cannot be pre-
cisely accounted for. However, Illumina HiSeq 2000 2 ×
100 bp sequencing was employed in the whole segment
mutant library approach, which offered a much deeper
coverage to increase confident in computing fitness effect.
Therefore, the profiling results from these two different
strategies would complement each other.
Transfections, infections, and titering
293T cells (human embryonic kidney cells) were trans-
fected with Lipofectamine 2000 (Life Technologies) using
the M segment mutant library plasmid (for screening pur-
pose) or point mutation plasmid (for validation purpose)
plus 7 other wild-type plasmids. Supernatant was replaced
with fresh cell growth medium at 24-hour and 48-hour
post-transfection. At 72-hour post-transfection, super-
natant containing infectious virus was harvested, filtered
through a 0.45 um MCE filter, and stored at −80 ◦C. The
viral titer (concentration of infectious particles) was mea-
sured by 50 % Tissue Culture Infective Dose (TCID50)
using on A549 cells (human lung carcinoma cells). In this
study, ∼5 million 293T cells were employed for transfec-
tion of each mutant library. We believed this amount of
293T cells were not sufficient to reconstitute all genotypes
and would create a huge bottleneck in genetic diversity.
If ∼35 million 293T cells (7-fold increase in cell num-
ber) were used instead as indicated in our recent study
[23], the bottleneck at the transfection step could be
hugely relieved and the correlation of RF indices between
replicates would be greatly improved.
Virus produced from the 293T transfection was used to
infect A549 cells at a multiplicity of infection (MOI) of
0.05. MOI represented the infectious virus to cell ratio.
Infected cells were washed with PBS followed by the addi-
tion of fresh cell growth medium at 2-hour post-infection.
Virus was harvested at 24-hour post-infection for screen-
ing experiment and validation, or at indicated time point
for growth curve experiment.
Sequencing library preparation
Viral RNA was extracted from the post-infection viral
mutant library using QIAamp Viral RNA Mini Kit
(Qiagen Sciences) and was reverse transcribed to
cDNA using Superscript III reverse transcriptase (Life
Technologies).
For the whole segment mutant library, DNA from
the plasmid library or cDNA from the post-infection
viral mutant library were amplified using the following
primers:
Amplicon 1: 5’-CTA CAC GAC GCT CTT CCG
ATC TNN NNN NAG ATG AGT CTT CTA ACC
GAG-3’ and 5’-TGC TGA ACC GCT CTT CCG
ATC TNN NNN NCC TAA AAT CCC CTT AGT
CAG-3’
Amplicon 2: 5’-CTA CAC GAC GCT CTT CCG
ATC TNN NNN NAA GAC CAA TCC TGT CAC
CT-3’ and 5’-TGC TGA ACC GCT CTT CCG ATC
TNN NNN NGA ATG TTA TCT CCC TCT TAA
G-3’
Amplicon 3: 5’-CTA CAC GAC GCT CTT CCG
ATC TNN NNN NGC AGT TAA ACT GTA TAG
GAA G-3’ and 5’-TGC TGA ACC GCT CTT CCG
ATC TNN NNN NAG TCA GCA ATC TGT TCA
CAG-3’
Amplicon 4: 5’-CTA CAC GAC GCT CTT CCG
ATC TNN NNN NTG GCC TGG TAT GCG CAA
C-3’ and 5’-TGC TGA ACC GCT CTT CCG ATC
TNN NNN NAA TAT CCA TGG CCT CTG CT-3’
Amplicon 5: 5’-CTA CAC GAC GCT CTT CCG
ATC TNN NNN NTG GAT CGA GTG AGC AAG
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C-3’ and 5’-TGC TGA ACC GCT CTT CCG ATC
TNN NNN NGG ATC ACT TGA ATC GTT GC-3’
Amplicon 6: 5’-CTA CAC GAC GCT CTT CCG
ATC TNN NNN NAA CGA ATG GGG GTG CAG
AT-3’ and 5’-TGC TGA ACC GCT CTT CCG ATC
TNN NNN NCC CTC ATA GAC TCT GGC A-3’
Amplicon 7: 5’-CTA CAC GAC GCT CTT CCG
ATC TNN NNN NAC TTG ATA TTG TGG ATT
CTT GA-3’ and 5’-TGC TGA ACC GCT CTT CCG
ATC TNN NNN NTA CTC CAG CTC TAT GTT
GAC-3’
Following PCR, 7 amplicon products were pooled
together. 0.875 million copies of the pooled product were
used as the input for the second PCR, which was equiv-
alent to 10 paired-end reads per molecule if 8.75 mil-
lion paired-end reads were sequenced. 5’-AAT GAT ACG
GCGACCACCGAGATCTACACTCTTTCCCTACA
CGA CGC TCT TCC G-3’ and 5’-CAA GCA GAA GAC
GGC ATA CGA GAT CGG TCT CGG CAT TCC TGC
TGA ACC GCT CTT CCG-3’ were used as the primers
for the second PCR. Products of the second PCR were
submitted for deep sequencing using Illumina HiSeq 2000
with 100 bp paired-end reads.
For the “small libraries”, DNA from the plasmid library
or cDNA from the post-infection viral mutant library were
amplified using the following primers:
Small library 1: 5’-TAG ATA CTG GAG GAT GAG
TCT TCT AAC C-3’ and 5’-TGT CCA CTG GAG
TTG GAT CTC CGT TCC C-3’
Small library 2: 5’-TAG ACG CTG GAG CCA AAA
TGC TCT TAA T-3’ and 5’-GTC TGA CTG GAG
GAT TGG TTG TTG TCA C-3’
Small library 3: 5’-CTC CCA CTG GAG GTC TCA
TAG GCA AAT G-3’ and 5’-AGG ATC CTG GAG
ATC GTT GCA TCT GCA C-3’
Small library 4: 5’-AAA AGA CTG GAG TCT TGA
AAA TTT ACA G-3’ and 5’-TTA CTC CTG GAG
TAT GTT GAC AAA ATG A-3’
The resulting PCR amplicons were digested with BpmI
(New England Biolabs), end-repaired by end repair mod-
ule (New England BioLabs), and 3’ dA-tailed by dA-tailing
module (New England BioLabs). dA-tailed amplicons
were ligated to sequencing adapters using T4 DNA lig-
ase (Life Technologies) as previously described [23]. The
adapter-ligated products were enriched by a final PCR
using primers: 5’-AAT GAT ACG GCG ACC ACC GAG
ATC TAC ACT CTT TCC CTA CAC GAC-3’ and 5’-
CAA GCA GAA GAC GGC ATA CGA GAT CGG TCT
CGG CAT TCC TGC TGA ACC-3’. Deep sequencing
was performed using Illumina MiSeq with 250 bp paired-
end reads. Raw sequencing data have been submitted to
the NIH Short Read Archive under accession number:
BioProject PRJNA285135.
Data analysis
Sequencing data were processed as described previously
for whole segment library [19] and for the “small libraries”
[23]. To increase statistic confidence in computing RF
index, two filters were applied as follow. 1) Those muta-
tions with an input count of < 30 error-corrected reads
in the whole segment mutant library were discarded. 2)
All C to A and G to T mutations were discarded due to
an observed DNA oxidative damage in sequencing library
preparation [68].
We aimed to identify deleterious mutations with high
confidence. Applying high-throughput genetics using the
influenza virus eight-plasmid reverse genetic system [67]
could produce many false positives in identifying delete-
rious mutations − a significant number of neutral muta-
tions may display as deleterious in the fitness profiling
result. This caveat was largely due to the huge bottleneck
effect in the transfection step, which was observed in mul-
tiple studies [19–21]. Briefly, each independently trans-
fected viral mutant library was an incomplete sampling of
mutants in the plasmid mutant library. To minimize the
artifact brought by the bottleneck effect, a conservative
estimate would be needed to compute the fitness effect
of individual point mutations for the purpose of identify-
ing deleterious mutations. As a result, for each mutation,
the RF indexmax, which represented the highest value
among the five RF indices from five biological replicates,
was used for the downstream analysis unless otherwise
stated. The RF indices are listed in Additional file 1. Those
mutations in the “small libraries” with an input frequency
of < 10-fold of the baseline frequency are listed as “NA”.
Baseline frequency represented the mutation introduced
in sequencing library preparation and was determined by
sequencing the WT plasmid.
True positive rate (TPR) was computed by:
TPR = number of nonsense mutations below fitness cutof fnumber of all nonsense mutations
False positive rate (FPR) was computed by:
FPR = number of silent mutations below fitness cutof fnumber of all silent mutations
Mutations resided within 200 bp from the termini of the
M segment were not considered in computing TPR and
FPR since mutations at the terminus regions could impose
a fitness cost by interrupting the cis-acting packaging sig-
nal [69], which was independent of the change in amino
acid sequence.
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Structural analysis
DSSP (http://www.cmbi.ru.nl/dssp.html) was used to
compute the solvent accessible surface area (SASA) for
each residue from the PDB structure [70]. SASA was
then normalized to the empirical scale reported in [71]
to obtain relative solvent accessibility (RSA). RSA was
computed for all except the terminal residues of both
chain A and chain B of the M1 dimer in both dimeric
form and monomeric form (PDB: 1EA3) [39]. Residues
with an RSA greater than 0.2 in both monomeric chain
A and monomeric chain B were classified as surface-
exposed residues (“Exposed” in Fig. 4d), as buried residues
otherwise (“Buried” in Fig. 4d). For each residue, the
ratio between the RSA computed from the dimeric form
to the RSA computed from the monomeric form was
calculated, and was notated by RSAdimeric/RSAmonomeric.
This ratio represented the reduction of RSA during M1
dimerization and was always less than or equal to 1.
Residue that was extensively involved in the dimeric inter-
face would have a low RSAdimeric/RSAmonomeric. Here,
we defined those surface-exposed residues that had
a RSAdimeric/RSAmonomeric of less than 0.5 as dimer-
interface residues (“Interface” in Fig. 4d).
Coevolution analysis
Protein sequences were obtained from Influenza Research
Database (www.fludb.org) [47] on August 29, 2014. The
sequence searching criteria included complete M1 or M2
protein sequences of human influenza A virus H1N1
subtype from all geographical locations with duplicate
sequences removed. Additionally, the option of “Exclude
all pH1N1 proteins” was applied to obtain the protein
sequence information of the seasonal influenza virus
strains, and the option of “Include only pH1N1 proteins”
was applied to obtain the protein sequence information
of the 2009 H1N1 pandemic swine influenza virus strains.
The sampling dates ranged from 1918 to 2014. One pro-
tein sequence with a different length as compared to
A/WSN/33 was removed. Subsequently, a total of 150
sequences of the seasonal influenza virus strains and 278
sequences of the 2009 pandemic swine influenza virus
strains were included in the downstream analysis. CAPS
was employed for identification of coevolving residues
[50]. All 428 sequences obtained from Influenza Research
Database were used for coevolution analysis with default
parameters. Of note, this set of sequences did not contain
any laboratory strain.
Additional file
Additional file 1: Supplementary Dataset 1: RF index for each
mutation. (XLS 364 kb)
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